TTNP - phase 3 trial on Probuphine (Pro-806) should be positive,currently there is a $4.50 target. But be cautious ,any little negative can send this downward.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.